Omega 3 fats to Reduce the Incidence of Prematurity: The ORIP Trial

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

The most significant perinatal problem in the world today is early preterm birth with its consequent threat to life and life-long health in survivors. Fish oils have been suggested to overcome this problem. Encouraging results have been obtained from small trials that need substantiation in a large well designed trial. The ORIP trial, involving approximately 5510 women, will provide a definitive answer to the question of whether maternal fish oils supplementation reduces early preterm birth.

Funded Activity Details

Start Date: 01-01-2013

End Date: 01-01-2017

Funding Scheme: Project Grants

Funding Amount: $2,705,590.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Public Nutrition Intervention

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

dietary fatty acids | docosahexaenoic acids | maternal nutrition | nutrition supplementation | pregnancy | premature birth | randomised controlled trial (RCT)